Clinical trial
Building a National Framework to Combat Antimicrobial Resistance in Primary Care (CANBuild-AMR): Study Protocol for an Impact Evaluation of the British Columbia Prescriber Feedback Program
NCT07431190 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Building a National Framework to Combat Antimicrobial Resistance in Primary Care (CANBuild-AMR): Study Protocol for an Impact Evaluation of the British Columbia Prescriber Feedback Program
- Lead sponsor
- University of British Columbia
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 17, 2026
- Completion date
- November 30, 2028
- Enrollment
- 7,626 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antibiotics, antimicrobial drug resistance, feedback, prescribing, quality improvement